We accelerate the present.ㅤWe build the future.
The future isn’t a distant promise.
At CyberLabs, it’s the result of consistent execution.
We bring management, governance, and technology into businesses, closing the gap between the future and the present.
About the Cyberlabs Group
CyberLabs was founded in 2018. Our mission is to drive business performance through cutting-edge technology and management, impacting millions of people every day as we consume, interpret, and create technology.technologies
Portfolio Companies
Through intelligent and scalable solutions, the company helps prevent cyber threats, fraud, and digital risks, protecting individuals, businesses, and their digital identities in an increasingly connected world. The Dfndr Security app is a leading solution for protection against viruses, scams, and identity theft.
Akad Seguros combines tradition and innovation to transform the insurance market through Artificial Intelligence, process automation, and data analytics. This approach enhances operational efficiency while keeping insurance brokers at the center of its distribution model. Exit
Sinatra.pro is an AI Observability and Agentic Hub platform built specifically for enterprise e-commerce and omnichannel retail. The company uses proprietary artificial intelligence to monitor complex store operations in real time, helping large brands detect and fix systemic errors before they impact revenue or customer experience.
r4Solution is a platform that processes royalty reports, automatically calculates splits among all parties involved, and makes direct payments to each rights holder in a secure, organized, and transparent manner.
An AI-powered sales platform and agent infrastructure for B2B teams that automates the entire sales cycle, including prospecting, meetings, and training via specialized agents. It utilizes integrated, real-time tools to optimize performance across channels in a secure, organized, and transparent manner.
Gcell 3D is a Brazilian deep-tech company based in Rio de Janeiro and incubated at COPPE/UFRJ, specializing in three-dimensional (3D) cell culture and tissue bioengineering. Founded in 2019, it focuses on producing human tissues in the laboratory for pharmaceutical and cosmetic testing, as well as for regenerative medicine.

Let’s build the future together
